SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1635Why the volatility in REGN today? Both AMGN and REGN showed significant volatilBiotech Jim-3/7/2014
1634REGN and the future of AMD treatment Today Ophthotech is holding an investor daBiotech Jim-3/7/2014
1633That is an incredible story, I am vey happy for you and your friend Lenny and hiTime2shine13/6/2014
1632Hello Time2shine- I have been following this stock pretty much since it went Biotech Jim13/6/2014
1631I am blown away this was first posted in 1996 trading in the teens and now tradiTime2shine-3/6/2014
16308K released today, on the dupilumab atopic dermatitis study. Great results. DuBiotech Jim-3/5/2014
1629Nice report... February 11, 2014 Regeneron Reports Fourth Quarter and Full YeaBiotech Jim12/11/2014
1628No offense but your opinion is wrong. Additionally you may wish to do some reseaHoodBuilder-2/11/2014
1627It's unlikely to work, IMO.DewDiligence_on_SI-2/5/2014
1626Any concerns over Ohr's Squalamine drop?Felix B-2/5/2014
1625For those who don't have paid access to NYT content, I excerpted portions ofDewDiligence_on_SI-1/13/2014
1624New clinical genetics genome initiative by Regeneron with the Geisinger clinics Biotech Jim-1/13/2014
1623Regeneron reports a collaboration with the American College of Cardiology (ACC) Biotech Jim-12/19/2013
1622Yeah, but this cherry picking CD19, CD20, etc. is disappointing to me. Low hangscaram(o)uche-12/3/2013
1621Interesting. Haven't done much research on this, but the recent IPO MacrogBiomaven-12/3/2013
1620So we finally hear something about the bispecific antibody program. In todayBiotech Jim-12/2/2013
1619FDA (still) accepts three CV surrogate endpoints: BP, LDL, and HbA1c, according DewDiligence_on_SI-11/19/2013
1618I am more concerned with this, "Yancopoulos said Amgen's rival drug migFelix B-10/30/2013
1617In the PFE call earlier this week, they commented on their PSCK9 antibody in devBiotech Jim-10/30/2013
1616REGN filed a lawsuit against Kymab for patent infringement on EP1360287, and KymBiotech Jim-10/10/2013
1615US Congressional bill will put some pressure on use of off-label Avastin: silicoDewDiligence_on_SI-9/26/2013
1614Have been debating making the same move or with RHHBY (to diversify since I am lFelix B-9/18/2013
1613Kinda on topic... This morning I picked up a bunch of shares in SNY, the ADR, wBiotech Jim-9/18/2013
1612I believe they terminated the 846 program from the last earnings call although IFelix B-9/13/2013
1611Those mAbs mentioned were from the REGN website. The Baird presentation given bBiotech Jim-9/13/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News